White House Drops FDA Nominee Overton: Who Leads the Agency Now
The White House has withdrawn Dr. Heidi Overton's nomination to lead the FDA, a day before her Senate committee vote, after she failed to win enough support.
Image: Wikimedia Commons / The U.S. Food and Drug Administration
WASHINGTON, Nov. 18 — The White House has withdrawn Dr. Heidi Overton's nomination to lead the Food and Drug Administration, a day before the Senate committee vote on advancing her to the full Senate.
A senior administration official said Overton "lacks the support on the Hill to move forward with her confirmation," and a White House official confirmed the decision late Tuesday. The Senate Health, Education, Labor and Pensions Committee had been scheduled to vote Wednesday on recommending her for a full floor vote.
Key Takeaways
- The White House withdrew Dr. Heidi Overton's FDA nomination late Tuesday, Nov. 17, hours before a scheduled Senate committee vote.
- Overton, a physician and White House domestic policy deputy, faced bipartisan opposition over vaccines, vaping and abortion.
- Attorney Kyle Diamantas leads the FDA as acting commissioner while the White House searches for a new nominee.
- Sen. Roger Marshall of Kansas has been discussed as a possible replacement; no new nominee has been named.
Why Did the White House Drop Heidi Overton's FDA Nomination?
The nomination exposed fault lines between the "Make America Healthy Again" movement, led by Health and Human Services Secretary Robert F. Kennedy Jr., and more traditional conservative circles. Senators cited her support for peeling back vaccine recommendations, her role in loosening vape restrictions, her abortion stance and alleged tobacco-industry ties.
Senate Health Committee chairman Bill Cassidy of Louisiana questioned Overton's involvement in administration vaccine policies and remained undecided ahead of the vote.
Kennedy praised the nomination in August, but people familiar with the relationship described it as "not good" and "icy." One said bluntly: "She's not MAHA." Overton, a senior White House domestic policy adviser, spent the past year and a half caught between Health Department leaders advancing MAHA policies and White House officials who stalled them.
Who Leads the FDA Now and Who Could Replace Overton?
Attorney Kyle Diamantas, who previously headed the FDA's food centre, continues to lead the agency on a temporary basis. He has held the acting role since Dr. Marty Makary left the commissioner's post in May. The FDA regulates products that account for roughly a fifth of consumer spending in the United States.
Health Secretary Robert F. Kennedy Jr. recently reached out to Sen. Roger Marshall of Kansas about taking Overton's place, according to a person familiar with the matter. Marshall, a physician, lost his re-election bid earlier this month, and Republicans have discussed him as a possible replacement.
What Happens Next for the FDA Nomination?
The Senate Health Committee still meets Wednesday morning, but Overton's nomination is off its agenda. The committee will instead vote on advancing Jim O'Neill, the nominee to direct the National Science Foundation, and picks for senior labour and education roles.
She was nominated by President Donald Trump in August and appeared before the committee at a confirmation hearing on Sept. 24. The White House must now restart its search for a permanent commissioner, with a safety review of the abortion pill mifepristone due to finish in March.
| Date | Development |
|---|---|
| August 2026 | Trump nominates Dr. Heidi Overton to lead the FDA |
| Sept. 24, 2026 | Overton appears at a Senate Health Committee hearing |
| Nov. 17, 2026 | White House withdraws the nomination |
| Nov. 18, 2026 | Senate committee vote on Overton cancelled |
| March 2027 | FDA safety review of mifepristone due to finish |
The White House has not said when it will name a new nominee. See also the Senate summons of Huang and Lutnick, the re-election of Thune as Senate GOP leader, and the FDA's GLP-1 vision-loss warning.
Frequently Asked Questions
Why was Heidi Overton's FDA nomination withdrawn?
Overton lacked the votes to advance in the Senate. She faced bipartisan pushback over vaccine recommendations, vaping rules and abortion, and the Senate Health Committee chairman had not committed to supporting her.
Who is leading the FDA now?
Attorney Kyle Diamantas is the acting FDA commissioner. He previously headed the agency's food centre and has held the acting role since Dr. Marty Makary left the post in May.
Who could replace Heidi Overton as FDA commissioner?
Sen. Roger Marshall of Kansas, a physician, has been discussed as a possible replacement, and Health Secretary Robert F. Kennedy Jr. has reached out to him.
What happens to the Senate committee vote on Heidi Overton?
The vote scheduled for Wednesday, Nov. 18, will not go ahead for Overton. The committee still meets to vote on other nominees, including Jim O'Neill to lead the National Science Foundation.